Guidelines in cryptococcosis - 2008;Consenso em criptococose - 2008

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 41, Issue 5, 2008, Pages 524-544

  Kon, Adriana Satie ^a   Grumach, Anete Svciaovic ^a   Colombo, Arnaldo Lopes ^b   Penalva, Augusto César Oliveira ^c   Wanke, Bodo ^d   Telles, Flavio De Queiroz ^e   Severo, Luiz Carlos ^f   Aranha, Luis Fernando ^b   Lazéra, Márcia Dos Santos ^d   Resende, Mariângela Ribeiro ^c   Salmito, Maria Do Amparo ^g   Shikanai Yasuda, Maria Aparecida ^a   Moretti, Maria Luiza ^c   Ferreira, Marcelo Simão ^h   Silva Vergara, Mario León ⁱ   Andrade, Najara Maria Procópio ^j   Trabasso, Plínio ^c   Mendes, Rinaldo Pôncio ^k   Martinez, Roberto ^a   Ponzio, Vinicius ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d Funda??o Oswaldo Cruz   (Brazil)

^e FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^f FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^g Laboratório de Pesquisas em Leishmanioses Instituto de Doenças Tropicais Natan Portela IDTNP   (Brazil)

^h FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

ⁱ FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

^j INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS   (Brazil)

^k SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPRENAVIR; ATAZANAVIR; DIDANOSINE; EFAVIRENZ; FLUCONAZOLE; INDINAVIR; ITRACONAZOLE; LOPINAVIR; NELFINAVIR; NEVIRAPINE; RITONAVIR; SAQUINAVIR; ZIDOVUDINE;

BACTERIUM ISOLATE; CLINICAL FEATURE; CRYPTOCOCCOSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; IN VITRO STUDY; INCIDENCE; INTRACRANIAL HYPERTENSION; LABORATORY TEST; MICROSCOPY; PRACTICE GUIDELINE; PREVALENCE; REVIEW; TREATMENT DURATION;

EID: 56549102444     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822008000500022     Document Type: Review

References (120)

1. Abadi J, Nachman S, Kressel AB, Pirofski L. Cryptococcosis in children with AIDS. Clinical of Infectious Diseases15: 796-800, 1996.
2. Aberg JA, Mundy LM, Powderly WG. Pulmonary cryptococcosis in patients without HIV. Chest 115:734-740, 1999.
3. Averbuch D, Boekhoutt T, Falk R, Engelhard D, Shapiro M, Block C, Polacheck I. Fungemia in a cancer patient caused by fluconazole-resistant Cryptococcus laurentii. Medical Mycology 40: 479-484, 2002.
4. Baddour LM, Perfect JR, Ostrosky-Zechener L. Successful use of amphotericin B lipid complex in the treatment of cryptococcosis. Clinical of Infectious Diseases 40 (suppl 6): 409-413, 2005.
5. Behrman RE, Masci JR, Nicholas P. Cryptococcal skeletal infections: case report and reviews. Review of Infectious Diseases 12:181-190, 1990.
6. Bennett JE, Dismukes WE, Duma RJ, Medoff G, Sande MA, Gallis H, Leonard J, Fields BT, Bradshaw M, Haywood H, McGee ZA, Cate TR, Cobbs CG, Warner JF, Alling DW. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. New England Journal of Medicine 301:126-131, 1979.
7. Benson CA, Kaplan JE, Masur H, Pau A, Holmes KK, CDC - Centers for Disease Control; National Institutes of Health; Infectious Diseases Society of America. Treating opportunistic infections among HIV infected adults and adolescents. MMWR -Morbidity and Mortality Weekly Report 53 (RR15): 1-112, 2004.
8. Bicanic T, Harrison T, Niepieklo A, Nontobeko D, Meintjes G. Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazol monotherapy: the role of fluconazole resistance and immune reconstitution. Clinical of Infectious Diseases 43: 1069-1073, 2006.
9. Bicanic T, Wood R, Meintjes Grebe, K, Brower A, Loyse A, Bekker LG, Jaffar S, Harrison T. High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial. Clinical of Infectious Diseases 47:123-130, 2008.
10. Brouwer AE, Rajanuwong A, Chierakul W, Griffin GE, Larsen RA, White NJ, Harrison TS. Combination antifungal therapies for HIV-associated crytptococcal meningitis: a randomized trial. Lancet 363:1764-1767, 2004.
11. Brouwer AE, van Kan HJ, Johnson E, Rajanuwong A, Teparrukkul P, Wuthiekanun V, Chierakul W, Day N, Harrison TS. Oral versus intravenous flucytosine in patients with human immunodeficiency virus-associated cryptococcal meningitis. Antimicrobial Agents Chemotherapy 51:1038-1042, 2007.
12. Bryan VS. Certebral osteomyelitis due to Cryptococcus neoformans. Journal of Bone and Joint Surgery 59A:275-278, 1977.
13. Calvo BM, Colombo AL, Fischman O, Santiago A, Thompson L, Lazera M, Telles F, Fukushima K, Nishimura K, Tanaka R, Myiajy M, Moretti-Branchini ML. Antifungal susceptibilities, varieties, and electrophoretic karyotypes of clinical isolates of Cryptococcus neoformans from Brazil, Chile, and Venezuela. Journal of Clinical Microbiology 39:2348-2350, 2001.
14. Cameron ML, Bartlett JA, Waskin HA. Manifestation of pulmonary cryptococcosis in patients with acquired immunodeficiency syndrome. Review of Infectious Diseases 13:64-67, 1991.
15. Campbell GD. Primary pulmonary cryptococcosis. American Review Respiratory Diseases 94:236-243, 1996. 16. Casadevall A, Perfect JR. Cryptococcus neoformans. ASM Press, Washington DC, 1998.
16. Castro G, Cervi MC, Martinez R. Vertical transmission of Cryptococcus neoformans from a mother coinfected with human immunodeficiency virus: case report. Revista da Sociedade Brasileira de Medicina Tropical 39:501-503, 2006.
17. Chandrasekar P. The experience is clear. International Journal Antimicrobial Agents 27S: 31-35, 2006.
18. Chuck SL, Sande MA. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. New England Journal of Medicine 321:794-799, 1989.
19. Correa MPSC, Oliveira EC, Duarte RRBS, Pardal PPO, Oliveira FM, Severo LC. Criptococose em crianças no estado do Pará, Brasil. Revista da Sociedade Brasileira de Medicina Tropical 32:505-508,1999.
20. Correa MPSC, Severo LC, Oliveira FM, Irion K, Londero AT. The spectrum of computerized tomography (CT) findings in central nervous system (CNS) infection due to Cryptococcus neoformans var. gattii in immunocompetent children. Revista do Instituto de Medicina Tropical de São Paulo 44:283-287, 2002.
21. Dannaoui E, Abdul M, Arpin M, Michel-Nguyen A, Piens MA, Favel A, Lortholary O, Dromer F; French Cryptococcosis Study Group. Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis. Antimicrobial Agents Chemotherapy 50:2464-2470, 2006.
22. Darze C, Lucena R, Gomes I, Melo A. Características clínicas e laboratoriais de 104 casos de meningoencefalite criptocócica. Revista da Sociedade Brasileira de Medicina Tropical 33: 21-26, 2000.
23. Delgado AC, Taguchi H, Mikami Y, Myiajy M, Villares MC, Moretti ML. Human cryptococcosis: relationship of environmental and clinical strains of Cryptococcus neoformans var. neoformans from urban and rural areas. Mycopathologia 159:7-11, 2005.
24. Diamond RD, Bennett JB. Prognostic factors in cryptococcal meningitis. A study of 111 cases. Annals of Internal Medicine 80:176-181, 1974.
25. Dismukes WE, Cloud G, Gallis HA, Kerkering TM, Medoff G, Craven PC, Kaplowitz LG, Fisher JF, Gregg CR, Bowles CA, et al. Treatment of cryptococcal meningitis with combination of amphotericin B and flucytosine for four as compared with six weeks. New England of Medicine 317:334-341, 1987.
26. Dromer F, Bernede-Bauduin C, Guillemot D, Lortholary O, French Cryptococcosis Study Group. Major role for amphotericin B-flucytosine combination in severe cryptococcosis. PLoS ONE 3: e2870, 2008.
27. Dromer F, Mathoulin-Pélissier S, Launay O, Lortholary O, French Cryptococcosis Study Group. Determinants of disease presentation and outcome during cryptococcosis: The crypto A/D study. PLoS Medicine 4:e21, 2007.
28. Ellis DH, Pfeiffer TJ. Ecology, life cycle, and infectious propagule of Cryptococcus neoformans. Lancet 336:923-925, 1990.
29. Ellis DH, Pfeiffer TJ. Natural habitat of Cryptococcus neoformans var. gattii. Journal Clinical Microbiology 28:1642-1644, 1990.
30. Engelke F, Moraes V. Interações medicamentosas dos anti-retrovirais. Jornal Brasileiro de AIDS 6:189-284, 2005.
31. Ferraz AS, Martins ACP, Becker PFL, Marques MMA, Suaid HJ, Ciconelli AJ. Criptococose disseminada pós-transplante renal. Revista do Instituto de Medicina Tropical de São Paulo 18:120-127, 1976.
32. Fessler RD, Sobel J, Guyot L, Crane L, Vazquez J, Szuba MJ, Diaz FG. Management of elevated intracranial pressure in patients with cryptococcal meningitis. Journal of Acquired Immune Deficiency Syndrome Human Retrovirology 17:137-142, 1998.
33. Filiú WF, Wanke B, Agüena SM, Vilela VO, Macedo RC, Lazéra M. Avian habitats as sources of Cryptococcus neoformans in the city of Campo Grande, Mato Grosso do Sul (Brazil). Revista da Sociedade Brasileira de Medicina Tropical 35:591-595, 2002.
34. Franzot SP, Salkin IF, Casadevall A. Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates. Journal of Clinical Microbiology 37:838-840, 1999.
35. Friese G, Discher T, Fussie R, Schmalreck A, Lohmeyer J. Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease AIDS 17:2344-2345, 2001.
36. Goldman DL, Khine H, Abadi J, Lindenberg DJ, Pirofski LA , Niang R, Casadevall A Serologic evidence for Cryptococcus neoformans infection in early childhood. Pediatrics 107:E66, 2001.
37. Graybill JR, Sobel J, Saag M, van Der Horst C, Powderly W, Cloud G, Riser L, Hamill R, Dismukes W. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Clinical of Infectious Diseases 30:47-54, 2000.
38. Hospenthal DR, Bennett JE. Persistence of cryptococcomas on neuroimaging. Clinical of Infectious Diseases. 31:1303-1306, 2000. Erratum in: Clinical of Infectious Diseases 32: 175, 2001.
39. Husain S, Wagener MM, Singh N. Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerging Infectious Diseases 7:375-381, 2001.
40. Igreja RP, Lazéra MS, Wanke B, Galhardo MC, Kidd SE, Meyer W. Molecular epidemiology of Cryptococcus neoformans isolates from AIDS patients of the Brazilian city, Rio de Janeiro. Medical Mycology 42:229-238, 2004.
41. Jenny-Avital ER, Abadi M. Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy. Clinical of Infectious Diseases 35:128-133, 2002.
42. John GT, Mathew M, Snehalatha E, Anandi V, Date A, Jacob CK. Cryptococcus in renal allograft recipients. Transplantation 58:855-856, 1994.
43. Katsu M, Kidd S, Ando A, Moretti-Branchini ML, Mikami Y, Nishimura K, Meyer W. The internal transcribed spacers and 5.8S rRNA gene show extensive diversity among isolates of the Cryptococcus neoformans species complex. FEMS Yeast Research 4:377-388, 2004.
44. Kerkering TM, Duma RJ, Shadomy S. The evolution of pulmonary cryptococcosis. Clinical implications from a study of 41 patients with or without compromising host factors. Annals of Internal Medicine 16:611-616, 1981.
45. Kiertiburanakul S, Sungkanuparph S, Buabut B, Pracharktam R. Cryptococcuria as a manifestation of disseminated cryptococcosis and isolated urinary tract infection. Japanese Journal of Infectious Diseases 57:203-205, 2004.
46. King CT, Rogers DP, Cleary JD, Chapman SW. Antifungal therapy during pregnancy. Clinical of Infectious Diseases 27:1151-1160, 1998.
47. Kovacs JA, Kovacs AA, Polis M, Wright WC, Gill VJ, Tuazon CU, Gelmman EP, Lane HC, Longfield R, Overturf G, Macher AM, Fauci AS, Parrilo JE, Bennett JE, Masur H. Cryptococcosis in the acquired immunodeficiency syndrome. Annals of Internal Medicine 103:533-538, 1985.
48. Kurokawa CS, Sugizaki MF, Peraçoli MTS Virulence factors in fungi of systemic mycoses Revista do Instituto de Medicina Tropical São Paulo 40:125-135, 1998.
49. Kwon-Chung KJ, Bennett JE. Epidemiologic differences between the two varieties of Cryptococcus neoformans. American Journal of Epidemiology 120:123-130, 1984.
50. Larsen RA, Leal MA, Chan LS. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomizes trial. Annals of Internal Medicine 113:183-187, 1990.
51. Larsen RA, Bozzeti S, McCutchan JA, Chiu J, Leal MA, Richman DD. Persistent Cryptococcus neoformans infection of the prostate after successful treatment of meningitis. Annals of Internal Medicine 111:125-128, 1989.
52. Lazéra MS, Cavalcanti MA, Trilles L, Nishikawa MM, Wanke B. Cryptococcus neoformans var. gattii evidence for a natural habitat related to decaying wood in a pottery tree hollow. Medical Mycology 36:119 -122, 1998.
53. Lazéra MS, Salmito Cavalcanti MA, Londero AT, Trilles L, Nishikawa MM, Wanke B. Possible primary ecological niche of Cryptococcus neoformans. Medical Mycology 38:379 -383, 2000.
54. Leenders AC, Reiss P, Portegies P, Clezy K, Hop WC, Hoy J, Borleffs JC, Allworth T, Kauffmann RH, Jones P, Kroon FP, Verbrugh HA, Marie S. Lipossomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis. AIDS 11:1463-1471, 1997.
55. Lief M, Sarfarazi F. Prostatic cryptococcosis in acquired immunodeficiency syndrome. Urology 28:318-319, 1986.
56. Lindenberg AS, Chang MR, Paniago AM, Lazéra MS, Moncada PM, Bonfim GF, Nogueira SA, Wanke B. Clinical and epidemiological features of 123 cases of cryptococcosis in Mato Grosso do Sul, Brazil. Revista do Instituto de Medicina Tropical de São Paulo 50:75-78, 2008.
57. Lizarazo J, Linares M, Bedout C, Restrepo A, Agudelo CI, Castañeda E, Grupo Colombiano para el Estudio de la Criptococosis. Results of nine years of the clinical and epidemiological survey on cryptococcosis in Colombia, 1997-2005. Biomedica 27:94-109, 2007.
58. Lortholary O. Management of cryptococcal meningitis in AIDS. The need for specific studies in developing countries. Clinical of Infectious Diseases 45:81-83, 2007.
59. Lortholary O, Fontanet A, Memain N, Martin A, Sitbon K, Dromer F. French Cryptococcosis Study Group. Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France. AIDS 19:1043-1049, 2005.
60. Macsween FK, Bicanic T, Brouwer AE, Marsh H, Macalllan DC, Harrison TS. Lumbar drainage for control of raised cerebrospinal fluid pressure in cryptococcal meningitis: case report and review. Journal of Infection 51:221-224, 2005.
61. Magliani W, Conti S, Arseni S, Salati A, Ravanetti L, Maffei DL, Giovati L, Polonelli L. Antibody-mediated protective immunity in fungal infections. New Microbiology 28:299-309, 2005.
62. Malessa R, Krams M, Hengge U, Weiller C, Reinhardt V, Volbracht L, Rauhut F, Brockmeyer NH. Elevation of intracranial pressure in acute AIDS-related cryptococcal meningitis. Clinical Investigation. 72:1020-1026,1994.
63. Mamo GJ, Rivero MA, Jacobs SC. Cryptococal prostatic abscess associated with the acquired immune deficiency syndrome. Journal of Urology 148:889-890, 1992.
64. Mayanja-Kizza H, Oishi K, Mitarai S, Yamashita H, Nalongo K, Watanabe K, Izumi T, Ococi-Jungala , Augustine K, Mugerwa R, Nagatake T, Matsumoto K. Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS. Clinical of Infectious Diseases 26:1362-1366, 1998.
65. Menichetti F, Fiorio M, Tosti A, Gatti G, Bruna Pasticci M, Miletich F, Marroni M, Bassetti D, Pauluzzi S. High dose fluconazole therapy for cryptococcal meningitis in patients with AIDS. Clinical of Infectious Diseases 22:838-840, 1996.
66. Meyohas MC, Roux P, Bollens D, Chouaid C, Rozenbaum W, Meynard JL, Poirot JL, Frottier J, Mayaud C. Pulmonary cryptococcosis: localized and disseminated infections in 27 patients with AIDS. Clinical of Infectious Diseases 21:628-633, 1995.
67. Milefchik E, Leal MA, Haubrich R, Bozzette SA, Tilles JG, Leedom JM, McCutchan JA, Larsen RA.. Fluconazole alone or combined with flucytosine for the treatment of AIDS-associated cryptococcal meningitis. Medical Mycology 46:393-395, 2008.
68. Miller Jr WT, Edelman JM, Miller WT. Cryptococcal pulmonary infections in patients with AIDS: radiographic appearance. Radiology 175:725-728, 1990.
69. Ministério da Saúde. Programa nacional de doenças sexualmente transmissíveis. Ministério da Saúde, Brasília, Ano I:44, 1999.
70. Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans. Clinical of Microbiology Review 8:515-548, 1995.
71. Mitchell DN, Sorrell TC. Pancoast's syndrome due to pulmonary infection with Cryptococcus neoformans variety gattii. Clinical of Infectious Diseases 14:1142-1144, 1992.
72. Montenegro H, Paula CR. Environmental isolation of Cryptococcus neoformans var. gattii and C. neoformans var. neoformans in the city of São Paulo, Brazil. Medical Mycology 38:385-390, 2000.
73. Moyses Neto M, Muglia V, Batista MSPN, Pisi TM, Saber LTS, Ferraz AS. Infecção por fungos e transplante renal: análise nos primeiros 500 pacientes transplantados no Hospital de Clínicas da Faculdade de Medicina de Ribeirão Preto - USP. Jornal Brasileiro de Nefrologia 17:162-170,1995.
74. Muccioli C, Belfort Junior R, Lottenberg C, Lima J, Santos P, Kim M, Abreu MT, Neves R. Manifestações oftalmológicas na AIDS: avaliação de 445 pacientes em um ano. Revista da Associação Médica Brasileira. 40:155-158, 1994.
75. Mussini C, Pezzotti P, Miró JM, Martinez E, de Quirós JCL, Cinque P, Borghi V, Bedini A, Domingo P, Cahn P, Bossi P, de Lucca A, Monforte AA, Nelson M, Nwokoto N, Helou S, Negroni R, Jacchetti G, Antinori S, Lazzarin A, Cossarizza A, Espósito R, Artinori A, Aberg JA for the international working group on cryptococcosis. Clinical of Infectious Diseases 38:565-571, 2004.
76. Nadrous HF, Antonios VS, Terrel CL, Ryu JH. Pulmonary cryptococcosis in non immunocompromised patients. Chest 124:2143-2147, 2003.
77. Newton PN, Thai le H, Tip NQ, Short JM, Chierakul W, Rajanuwong A, Pitisuttithum P, Chasombat S, Phonrat B, Maek-A-Nantawat W, Teaunadi R, Lalloo DG, White NJ. A randomized, double blind placebo-controlled trial of acetazolamide for the treatment of elevated intracranial pressure in cryptococcal meningitis. Clinical of Infectious Diseases 35:769-772, 2002.
78. Nishikawa MM, Lazera MS, Barbosa GG, Trilles L, Balassiano BR, Macedo RC, Bezerra CC, Pérez MA, Cardarelli P, Wanke B. Serotyping of 467 Cryptococcus neoformans isolates from clinical and environmental sources in Brazil: analysis of host and regional patterns. Journal of Clinical Microbiology 41:73-77, 2003.
79. Nucci A, Maciel Júnior JA, Queiroz LS, Montenegro MA, Carvalho RB. Pseudocystic form of neurocryptococcosis in pregnancy. Case report. Arquivos de Neuropsiquiatria 57:678-682, 1999.
80. Pappas PG. Managing cryptococcal meningitis is about handling the pressure. Clinical of Infectious Diseases 40:480-482, 2005.
81. Pappas PG, Perfect JR, Cloud GA, Larsen R A, Pankey GA, Lancaster DJ, Henderson H, Kauffman CA, Haas DW, Saccente M, Hamill RJ, Holloway MS, Warren RM. Dismukes WE. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clinical of Infectious Diseases 33:690-699, 2001.
82. Passoni LF, Wanke B, Nishikawa MM, Lazéra MS. Cryptococcus neoformans isolated from human dwellings in Rio de Janeiro, Brazil: an analysis of the domestic environment of AIDS patients with and without cryptococcosis. Medical Mycology 36:305-311, 1998.
83. Patel R, Paya CV. Infections in solid-organ transplant recipients. Clinical of Microbiology Review 10:86-124, 1997.
84. Paya CV. Fungal infections in solid-organ transplantation. Clinical of Infectious Diseases 16:677-688, 1993.
85. Perfect JR, Marr KA, Walsh TJ, Greenberg RN, DuPont B, Torre-Cisneros J, Just-Nübling G, Schlamm HT, Lutsar I, Espinel-Ingroff A, Johnson E. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clinical Infectious Diseases 36:1122-1131, 2003.
86. Perfect JR, Casadevall A. Cryptococcosis. Infection Diseases Clinical of North American 16:837-874, 2002.
87. Pinto Jr VL, Galhardo MCG, Lazéra M, Wanke B, Reis RS, Perez M. Criptococose associada a aids: a importância do cultivo na urina no seu diagnostico. Revista da Sociedade Brasileira de Medicina Tropical 39:230-232, 2006.
88. Pitisuttithurm P, Negroni R, Graybill JR, Bustamante B, Pappas P, Chapman S, Hare RS, Hardalo CJ. Activity of posaconazole in the treatment of central nervous system fungal infections. Journal of Antimicrobial Chemotherapy 56:745-755, 2005.
89. Powderly WG. Recent advances in the management of cryptococcal meningitis in patients with AIDS. Clinical of Infectious Diseases 22 (suppl 2): 5119-5123, 1996.
90. Quintero E, Castañeda E, Ruiz A. Environmental distribution of Cryptococcus neoformans in the department of Cundinamarca-Colombia. Revista Iberoamericana de Micologia 22:93-98, 2005.
91. Revenga F, Paricio JF, Merino FJ, Nebreda T, Ram1rez T, Mart1nez AM. Primary Cutaneous Cryptococcosis in an Immunocompetent Host: Case Report and Review of the Literature. Dermatology 204:145-149, 2002.
92. Rodrigues ML, Alviano CS, Travassos LR. Pathogenicity of Cryptococcus neoformans: virulence factors and immunological mechanisms Microbes Infection 1:293-301, 1999.
93. Rozenbaum R, Gonçalves AR. Clinical epidemiological study of 171 cases of Cryptococcosis. Clinical of Infectious Diseases 18:369-380, 1994.
94. Saag MS, Cloud GA, Graybill JR, Sobel JD, Tuazon CU, Johnson PC, Fessel WJ, Moskovitz BL, Wiesinger B, Cosmatos D, Riser L, Thomas C, Hafner R, Dismukes WE. A comparison of intraconazole versus fluconazole as maintenance therapy for AIDS associated cryptococcal meningitis. Clinical of Infectious Diseases 28:291-296, 1999.
95. Saag MS, Graybill RJ, Larsen RA, Pappas PG, Perfect JR, Powderly WG, Sobel JD, Dismukes WE. Practice guidelines for the management of cryptococcal meningitis. Clinical of Infectious Diseases 30:710-718, 2000.
96. Saag MS, Powderly WG, Cloud GA, Robinson P, Grieco MH, Sharkey PK, Thompson SE, Sugar AM, Tuazon CU, Fisher JF, et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associate cryptococcal meningitis New England of Journal Medicine 326:83-89, 1992.
97. Salyer WR, Salyer DC. Involvement of the kidney and prostata in cryptococcosis. Journal of Urology 109:695-698, 1973.
98. Seaton RA, Verma N, Naraqi S, Wembri JP, Warrell DA. Visual loss in immunocompetent patients with Cryptococcus neoformans var. gattii meningitis. Transactions Royal Society Tropical Medical Hygiene 91: 44-49, 1997.
99. Seo IY, Jeong HJ, Yun KJ, Rim JS. Granulomatous cryptococcal prostatitis diagnosed by transrectal biopsy. International Journal of Urology 13: 638-639, 2006.
100. Sharkey PK, Graybill JR, Johnson ES, Hausrath SG, Pollard RB, Kolokathis A, Mildvan D, Fan-Havard P, Eng RH, Patterson TF, Pottage Jr JC, Simberkoff MS, Wolf J, Meyer RD, Gupta R, Lee LW, Gordon DS. Amphotericin B complex compared with Amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS. Clinical of Infectious Diseases 22: 315-321, 1996.
101. Shoham S, Cover C, Donegan N, Fulnecky E, Kumar P. Cryptococcus neoformans meningitis at 2 hospitals in Washington, DC: adherence of health care providers to published practice guidelines for the management of cryptococcal disease. Clinical of Infectious Diseases 40: 477-479, 2005.
102. Shoham S, Levitz SM. The immune response to fungal infections. British Journal of Hematology 129: 569-582, 2005.
103. Singh N, Alexander BD, Lortholary O, Dromer F, Gupta KL, John GT, del Busto R, Klintmalm GB, Somani J, Lyon GM, Pursell K, Stosor V, Muñoz P, Limaye AP, Kalil AC, Pruett TL, Garcia-Diaz J, Humar A, Houston S, House AA, Wray D, Orloff S, Dowdy LA, Fisher RA, Heitman J, Wagener MM, Husain S. Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen. Clinical of Infectious Diseases 46: 12-18, 2008.
104. Singh N, Lortholary O, Alexander BD, Gupta KL, John GT, Pursell K, Munoz P, Klintmalm GB, Stosor V, del Busto R, Limaye AP, Somani J, Lyon M, Houston S, House AA, Pruett TL, Orloff S, Humar A, Dowdy L, Garcia-Diaz J, Kalil AC, Fisher RA, Husain S; Cryptococcal Collaborative Transplant Study Group. An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients. Clinical of Infectious Diseases 40: 1756-1761, 2005.
105. Singh N, Lortholary O, Alexander BD, Gupta KL, John GT, Pursell KJ, Muñoz P, Klintmalm GB, Stosor V, Del Busto R, Limaye AP, Somani J, Lyon M, Houston S, House AA, Pruett TL, Orloff S, Humar A, Dowdy LA, Garcia-Diaz J, Kalil AC, Fisher RA, Heitman J, Husain S. Antifungal management practices and evolution of infection in organ transplant recipients with Cryptococcus neoformans infection. Transplantation 80: 1033-1039, 2005.
106. Singh N, Lortholary O, Alexander BD, Gupta KL, John GT, Pursell K, Munoz P, Klintmalm GB, Stosor V, Del Busto R, Limaye AP, Somani J, Lyon M, Houston S, House AA, Pruett TL, Orloff S, Humar A, Dowdy L, Garcia-Diaz J, Fisher RA, Husain S, Cryptococcal Collaborative Transplant Study Group. Allograft loss in renal transplant recipients with Cryptococcus neoformans associated immune reconstitution syndrome. Transplantation 80:1131-1133, 2005
107. Staib F, Seibold M, Láge M, Heise W, Skörde J, Grosse G, Nürnberger F, Bauer G. Cryptococcus neoformans in the seminal fluid of an AIDS patient. A contribution to the clinical course of cryptococcosis. Mycoses 32:171-180, 1989.
108. Stamm AM, Diasio RB, Dismukes WE, Shadomy S, Cloud GA, Bowles CA, Karam GH, Espinel-Ingroff A. Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis. American Journal of Medicine 83:236-242, 1987.
109. Swinne D, De Vroey C. Detection of circulating capsular polysaccharide antigen from Cryptococcus neoformans. Journal of Clinical Microbiology 30:2521, 1992.
110. Swinne D, Deppner M, Laroche R, Floch JJ, Kadende P. Isolation of Cryptococcus neoformans from houses of AIDS-associated cryptococcosis patients in Bujumbura (Burundi). AIDS 3: 389-390, 1989.
111. Swinne D, Nkurikiyinfura JB, Muyembe TL. Clinical isolates of Cryptococcus neoformans from Zaire. European Journal Clinical Microbiology 5: 50-51, 1986.
112. van der Horst CM, Saag MS, Cloud GA, Hamill RJ, Graybill JR, Sobel JD, Johnson PC, Tuazon CU, Kerkering T, Moskovitz BL, Powderly WG, Dismukes WE. The National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. Treatment of cryptococcal meningitis associated with acquired immunodeficiency syndrome. New England of Journal Medicine 337:15-21, 1997.
113. Venkataramanan R, Zang S, Gayowski T, Singh N. Voriconazole inhibition of the metabolism of tacrolimus in a liver transplant recipient and in human liver microsomes. Antimicrobial Agents and Chemotherapy 46: 3091-3093, 2002.
114. Verma N, Kearney J. Ocular manifestations of AIDS. Papua and New Guinea Medical Journal 39:196-199, 1996.
115. Vibhagool A, Sungkanuparph S, Mootsikapun P, Chetchotisakd P, Tansuphaswaswadikul S, Bowonwatanuwong C, Ingsathit A. Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study. Clinical of Infectious Diseases 36:1329-1331, 2003.
116. Vilchez R, Shapiro R, McCurry K, Kormos R, Abu-Elmagd K, Fung J, Kusne S. Longitudinal study of cryptococcosis in adult solid-organ transplant recipients. Transplant International 16: 336-340, 2003.
117. Vilchez RA, Fung J, Kusne S. Cryptococcosis in organ transplant recipients: an overview. American Journal of Transplantation 2:575-580, 2002.
118. Vilchez RA, Irish W, Lacomis J, Costello P, Fung J, Kusne S. The clinical epidemiology of pulmonary cryptococcosis in non-AIDS patients at a tertiary care medical center. Medicine 80: 308-312, 2001
119. Wu G, Vilchez RA, Eidelman B, Fung J, Kormos R, Kusne S. Cryptococcal meningitis: an analysis among 5,521 consecutive organ transplant recipients. Transplantation Infectious Diseases. 4: 183-188, 2002.
120. Yao Z, Liao W, Chen R. Management of cryptococcosis in non-HIV related patients. Medical Mycology 43:245-251, 2005.